Role of Alanine Transaminase and Transient Elastography in Categorising Nonalcoholic Fatty Liver Disease Subgroups

被引:1
作者
Shabbir, Asma [1 ]
Abbas, Zaigham [2 ]
Khatoon, Ambrina [3 ]
Mirza, Talat [4 ]
机构
[1] Ziauddin Univ, Dept Pathol, Karachi, Pakistan
[2] Ziauddin Univ, Dept Gastroenterol & Hepatol, Karachi, Pakistan
[3] Ziauddin Univ, Dept Mol Med, Karachi, Pakistan
[4] Ziauddin Univ, Dept Res, Karachi, Pakistan
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2024年 / 34卷 / 01期
关键词
Nonalcoholic fatty liver disease; Cirrhosis; Transient elastography; STEATOHEPATITIS;
D O I
10.29271/jcpsp.2024.01.22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate the association of alanine transaminase (ALT) with transient elastography grades to define various nonalcoholic fatty liver disease (NAFLD) groups for disease status.Study Design: Cross-sectional, descriptive study.Place and Duration of the Study: Gastroenterology Outpatient Clinic, Ziauddin Hospital, from January to December 2022.Methodology: This study included 194 NAFLD patients. Demographic data, body mass index, enzymes, and transient elastography (TE) findings were recorded. NAFLD patients were categorised as nonalcoholic fatty liver (NAFL), nonalcoholic steatohepatitis (NASH), steatofibrosis (significant fibrosis F2-F3 with normal ALT), and cirrhosis using TE grades.Results: The median age of the patients was 44 [IQR 18.25] years; 146 (75.3%) were males. Out of 194 NAFLD patients, 21 (10.8%) were NAFL, 116 (59.8%) were NASH, 14 (7.2%) showed steatofibrosis, and 43 (22.2%) were cirrhotic. On transient elastography, the majority were with S3 steatosis (n=107, 55.2%) and 59 (30.2%) had F0-F1 fibrosis. There was a statistically significant difference in the mean rank of age, ALT, AST, and GGT levels within 4 groups of NAFLD (p <0.001). Most of the patients with all the stages of fibrosis had increased ALT levels (p=0.034).Conclusion: This study concluded that a combination of ALT levels and transient elastography findings could be considered for differentiating uncomplicated steatosis from NASH, steatofibrosis, and cirrhosis, hence limiting the use of liver biopsy. This may prove a reliable way to measure the severity of the disease.
引用
收藏
页码:22 / 26
页数:5
相关论文
共 50 条
[31]   Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter [J].
Elkabany, Zeinab Anwar ;
Hamza, Rasha Tarif ;
Ismail, Eman Abdel Rahman ;
Elsharkawy, Aisha ;
Yosry, Ayman ;
Musa, Sherief ;
Khalaf, Marwa Ahmad ;
Elgawesh, Roba Maher ;
Esmat, Gamal .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (08) :1008-1016
[32]   The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease [J].
Simental-Mendia, Luis E. ;
Rodriguez-Hernandez, Heriberto ;
Rodriguez-Moran, Martha ;
Guerrero-Romero, Fernando .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (10) :1173-1177
[33]   Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease [J].
Siddiqui, Mohammad S. ;
Vuppalanchi, Raj ;
Van Natta, Mark L. ;
Hallinan, Erin ;
Kowdley, Kris V. ;
Abdelmalek, Manal ;
Neuschwander-Tetri, Brent A. ;
Loomba, Rohit ;
Dasarathy, Srinivasan ;
Brandman, Danielle ;
Doo, Edward ;
Tonascia, James A. ;
Kleiner, David E. ;
Chalasani, Naga ;
Sanyal, Arun J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) :156-+
[34]   Transient elastography with controlled attenuation parameter for the diagnosis of colorectal polyps in patients with nonalcoholic fatty liver disease [J].
Wang, Lan ;
Li, Yan-Fei ;
Dong, Li-Feng .
WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (12)
[35]   Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography [J].
Palumbo, Chiara Saroli ;
Restellini, Sophie ;
Chao, Che-Yung ;
Aruljothy, Achuthan ;
Lemieux, Carolyne ;
Wild, Gary ;
Afif, Waqqas ;
Lakatos, Peter L. ;
Bitton, Alain ;
Cocciolillo, Sila ;
Ghali, Peter ;
Bessissow, Talat ;
Sebastiani, Giada .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (01) :124-133
[36]   Alcoholic/Nonalcoholic Fatty Liver Disease Detection with Transient Elastography: A Detailed Review and Meta-analysis [J].
Fang, Yinyou ;
Li, Xiaofei ;
Zong, Fang ;
Jiang, Tianan .
CURRENT MEDICAL IMAGING, 2024, 20
[37]   Role of vitamin E in nonalcoholic fatty liver disease [J].
Nagashimada, Mayumi ;
Ota, Tsuguhito .
IUBMB LIFE, 2019, 71 (04) :516-522
[38]   The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease [J].
Doumas, Michael ;
Imprialos, Konstantinos ;
Dimakopoulou, Aikaterini ;
Stavropoulos, Konstantinos ;
Binas, Athanasios ;
Athyros, Vasilios G. .
CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (38) :4587-4592
[39]   Role of histone deacetylase on nonalcoholic fatty liver disease [J].
Fu, Shifeng ;
Yu, Meihong ;
Tan, Yuyong ;
Liu, Deliang .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (04) :353-361
[40]   Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease [J].
Aqel, Bashar ;
DiBaise, John K. .
NUTRITION IN CLINICAL PRACTICE, 2015, 30 (06) :780-786